Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00132578-200407000-00018PMID 14662586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk analysis of prethreshold retinopathy of prematurity.

  2003cited by this paper
• Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity.

  2003cited by this paper
• Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.

  2002cited by this paper
• Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.

  2001cited by this paper
• The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP).

  2001cited by this paper
• Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.

  2000cited by this paper
• Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994.

  2000cited by this paper
• Severity of Neonatal Retinopathy of Prematurity Is Predictive of Neurodevelopmental Functional Outcome at Age 5.5 Years

  2000cited by this paper
• Childhood blindness.

  1999cited by this paper
• Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

  1999cited by this paper
• Children with blindness due to retinopathy of prematurity: a population‐based study. Perinatal data, neurological and ophthalmological outcome

  1998cited by this paper
• Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group.

  1998cited by this paper
• Early treatment of posterior retinopathy of prematurity: a controlled trial.

  1997cited by this paper
• Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization.

  1996cited by this paper
• Monocular acuity norms for the Teller Acuity Cards between ages one month and four years.

  1995cited by this paper
• Large sample population age norms for visual acuities obtained with Vistech-Teller Acuity Cards.

  1995cited by this paper
• Assessing Visual Acuity of Visually Impaired Children Using the Teller Acuity Card Procedure

  1992cited by this paper
• Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.

  1991cited by this paper
• Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial.

  1990cited by this paper
• Childhood blindness

  1988cited by this paper
• Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

  1988cited by this paper
• ASSESSMENT OF VISUAL ACUITY IN INFANTS AND CHILDREN; THE ACUITY CARD PROCEDURE

  1986cited by this paper
• The acuity card procedure: a rapid test of infant acuity.

  1985cited by this paper
• An international classification of retinopathy of prematurity.

  1984cited by this paper
• New visual acuity charts for clinical research.

  1982cited by this paper
• The Denver developmental screening test.

  1967cited by this paper
• Retrolental Fibroplasia *: The Fifth Francis I. Proctor Lecture

  1951cited by this paper
• Methods of Diagnosis

  year unknowncited by this paper

• Retinopatía del Prematuro en Guatemala: Estudio Multicéntrico sobre las Características Clínicas en los Casos Tratados entre 2020 y 2024

  2026cites this paper
• Proteomic Profile in Retinopathy of Prematurity

  2026cites this paper
• Prevalence and risk factors of retinopathy of prematurity among preterm neonates admitted to a tertiary care hospital

  2026cites this paper
• Evaluation of the frequency, risk factors and outcomes of ROP in preterm infants with a BW >1500 g or GA >32 weeks in Turkiye (TR-ROP 2) and medicolegal fears: a Turkish Neonatal Society multicentre study

  2026cites this paper
• Myopia of Prematurity: Reduced Progression Using Highly Aspherical Lenslet Target (HALT) Technology

  2026cites this paper
• Hypertensive disorders of pregnancy and retinopathy of prematurity in extremely preterm infants: A causal mediation analysis.

  2026cites this paper
• Quantitative assessment of the extent of retinal vascularisation in retinopathy of prematurity

  2026cites this paper
• The Clinical Association of Maternal Asthma and the Development of Retinopathy of Prematurity in Preterm Infants.

  2026cites this paper
• Retinopathy of prematurity epidemiology and treatment trend in a tertiary medical center in Taiwan: From 2016 to 2023

  2026cites this paper
• Retinal blood flow decreases following treatment with laser photocoagulation for retinopathy of prematurity

  2026cites this paper
• Ten-year changes in risk factors for requiring treatment of retinopathy of prematurity in extremely low birth weight infants: a multicenter study in Tokyo.

  2026cites this paper
• Ophthalmological outcomes, visual perception, fine motor precision, and visual-motor integration in children born very preterm.

  2026cites this paper
• Oxygenation Instability and Short‐Term Morbidities Among Very‐Low‐Birthweight Premature Infants

  2025cites this paper
• Evaluation of timed dexamethasone eye drops to prevent proliferative retinopathy of prematurity: a study protocol for a randomized intervention, multi-centre, double-blinded trial (DROPROP)

  2025cites this paper
• Visual fields after anti-vascular endothelial growth factor therapy for retinopathy of prematurity

  2025cites this paper
• G-ROP versus WINROP for retinopathy of prematurity screening: a Calgary perspective.

  2025cites this paper
• Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment

  2025cites this paper
• Comparing safety and efficacy of Bevacizumab, Ranibizumab and Ranibizumab biosimilar in Retinopathy of prematurity

  2025cites this paper
• How does bovine milk‐based fortification alter the oxidant–antioxidant profile of breast milk in preterm infants?

  2025cites this paper
• Validation of the 'TWO-ROP' algorithm in a tertiary Care Centre in Greece.

  2025cites this paper
• Early applicability of retinopathy of prematurity score (ROPScore) and serum insulin growth factor-1 (IGF-1) for predicting treatment-requiring retinopathy of prematurity: a prospective cohort study

  2025cites this paper
• Long-Term Outcome of Xenon-Arc Photocoagulation for Retinopathy of Prematurity in the 1970s in Japan: Eleven Patients With 32- to 49-Year Follow-Up

  2025cites this paper
• Fetal Hemoglobin as a Predictive Biomarker for Retinopathy of Prematurity: A Prospective Multicenter Cohort Study in Portugal

  2025influential citation
• A meta-analysis of intravitreal ranibizumab versus laser photocoagulation for the treatment of retinopathy of prematurity.

  2025cites this paper
• Follow-up Algorithm after Bevacizumab Treatment for Retinopathy of Prematurity.

  2025cites this paper
• The association between red blood cell transfusion timing and the development of retinopathy of prematurity: Application of the two‐phase theory

  2025cites this paper
• The Impact of Low Birth Weight and Gestational Age on Premature Retinopathy Outcomes

  2025cites this paper
• Validation of the SCREENROP Criteria for Retinopathy of Prematurity Screening: A Canadian Model for Consideration.

  2025cites this paper
• Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases

  2025cites this paper
• Deep learning algorithms for timely diagnosis of retinopathy of prematurity requiring treatment

  2025cites this paper
• Incidence and Risk Factors of Retinopathy of Prematurity in a Tertiary Care Hospital in Western India

  2025cites this paper
• The U.S.A. eligible retinopathy of prematurity screening population 2003-2022: WONDER-ROP Study.

  2025cites this paper
• Polyunsaturated fatty acid balance modulates microglial state in a murine model of oxygen-induced neovascularization

  2025cites this paper
• Machine Learning Models for Predicting Treatment-Requiring Retinopathy of Prematurity in the e-ROP Study

  2025cites this paper
• Incidence, risk factors, and outcomes of nephrocalcinosis in preterm infants: a prospective cohort study

  2025cites this paper
• Safety and efficacy of limited laser therapy for type I mid-zone II retinopathy of prematurity

  2025cites this paper
• Association between mixed fatty acid emulsion and parenteral nutrition–associated cholestasis in extremely low‐birth‐weight infants: A retrospective cohort study

  2025cites this paper
• Incidence, risk factors and evolving treatment of severe retinopathy of prematurity in China: a retrospective multicenter cohort study in 70 neonatal intensive care units

  2025cites this paper
• Postnatal Weight Gain and Severe Retinopathy of Prematurity in Very Low Birth Weight Infants: A Retrospective Study

  2025cites this paper
• Analysis of the incidence and risk factors associated with retinopathy of prematurity in patients complicated by bronchopulmonary dysplasia

  2025cites this paper
• Machine Learning Risk Prediction for Treated Retinopathy of Prematurity in Infants.

  2025cites this paper
• Real-World Visual and Anatomical Outcomes of Laser Therapy versus Intravitreal Anti-Vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A 10-Year Retrospective Cohort Study at a Tertiary Center in Thailand

  2025cites this paper
• Risk factors for the development and progression of retinopathy of prematurity and the optimization of its screening

  2025cites this paper
• Construction of a predictive model for retinopathy of prematurity using machine learning algorithms

  2025cites this paper
• Pediatric Telemedicine-based Retinal Screening in Ghana

  2025cites this paper
• The prevalence, risk factors and outcomes of retinopathy of prematurity at a tertiary care centre in South Africa.

  2025cites this paper
• Clinical effects of the 2021 update of the Turkish retinopathy of prematurity guideline

  2025cites this paper
• Ophthalmic Outcomes in Preterm Infants.

  2025cites this paper
• Prediction Models for Retinopathy of Prematurity Using Nonimaging Machine Learning Approaches: A Regional Multicenter Study

  2025cites this paper
• Association between Early Postnatal Hydrocortisone and Retinopathy of Prematurity in Extremely Preterm Infants

  2025cites this paper
• Therapeutic outcomes of ranibizumab for zone ii stage 2 retinopathy of prematurity with plus disease

  2025cites this paper
• Low Dose Bevacizumab 0.03 mg for Treatment of Type I Retinopathy of Prematurity.

  2025cites this paper
• Modeling and Recognition of Retinal Blood Vessels Tortuosity in ROP Plus Disease: A Hybrid Segmentation–Classification Scheme

  2025cites this paper
• Insights into retinopathy of prematurity incidence: Contrasting small vs. appropriate size for gestational age premature infants at a tertiary eye care institute in central India

  2025cites this paper
• A novel methodology based on Contrast-Adaptive Threshold Model for accurate optic disc detection in retinal images of premature infants

  2025cites this paper
• Impact of early nutrition on brain development and neurocognitive outcomes in very preterm infants

  2025cites this paper
• Identification of genetic factors underlying severe retinopathy of prematurity in preterm infants

  2025cites this paper
• Persistent avascular retina in retinopathy of prematurity

  2025cites this paper
• Effect of Benoxinate Hydrochloride Eye Drops on the Premature Infant Pain Profile Score during Retinopathy of Prematurity Screening

  2025cites this paper
• Association of hypertensive disorders of pregnancy and gestational diabetes mellitus with developing severe retinopathy of prematurity

  2025cites this paper
• Treating retinopathy of prematurity with dexamethasone eye drops: a difference-in-differences study in Sweden using register data.

  2025cites this paper
• Safety and Efficacy of Combination Therapy with Anti-Vascular Endothelial Growth Factor and Laser for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis

  2025cites this paper
• Risk factors for reoperation in vitrectomy for stage 4A retinopathy of prematurity.

  2025cites this paper
• Risk factors for retinopathy of prematurity among preterm infants with bronchopulmonary dysplasia

  2025cites this paper
• Development of a scoring model integrating inflammatory markers for predicting ROP in preterm neonates

  2025cites this paper
• Area deprivation index predicts follow-up in retinopathy of prematurity.

  2025cites this paper
• Retrospective validation of the postnatal growth and retinopathy of prematurity criteria in a Chinese cohort

  2025cites this paper
• Repeat Intravitreal Bevacizumab in a Very Low Birth Weight Infant with Recurrent ROP: 3-Year Follow-Up and Literature Review

  2025cites this paper
• Refractive status and ocular characteristics of preschool children with retinopathy of prematurity after different treatments.

  2025cites this paper
• Impact of anti‐VEGF therapy versus laser therapy on mortality and treatment outcomes in retinopathy of prematurity: A systematic review and meta‐analysis

  2025cites this paper
• Epidemiological Profile of Retinopathy of Prematurity in Central India

  2025cites this paper
• Exploring the role of glycemic variability in the development of treatment-requiring retinopathy of prematurity

  2025cites this paper
• Foveal Identification and Development in Prematurity–Implications on Zone Localization and Nutritional Supplementation

  2025cites this paper
• Analysis of regional coverage for retinopathy of prematurity in the United States.

  2025cites this paper
• Determination of miRNA in tear extracellular vesicles significantly associated with treatment-requiring retinopathy of prematurity: a pilot study

  2025cites this paper
• Audit of a retinopathy of prematurity screening programme in the Limpopo province, South Africa

  2025cites this paper
• Review of Retinopathy of Prematurity Management in the Anti‐VEGF Era: Evolving Global Paradigms, Persistent Challenges and Our AI‐Assisted Future

  2025cites this paper
• Predicting the treatment-requiring retinopathy of prematurity using birth weight, laboratory data and continuous peripheral capillary oxygen saturation monitoring.

  2025cites this paper
• Clinical Outcomes of Very Low Birth Weight Infants until Hospital Discharge over Two Decades: A Cohort Study in a Tertiary Hospital in Riyadh, Kingdom of Saudi Arabia

  2025cites this paper
• Management of retinopathy of prematurity in the anti-VEGF era: Consensus and recommendations from the Taiwan Pediatric Retina (TPR) Group.

  2025cites this paper
• Artificial intelligence‐based algorithms for the diagnosis of retinopathy of prematurity

  2025cites this paper
• Topical Fasudil in Type 2 Retinopathy of Prematurity: A Pilot Study

  2025cites this paper
• Swept-source optical coherence tomography analysis of retinal and choroidal structures in school-aged children after laser photocoagulation for type 1 retinopathy of prematurity

  2025cites this paper
• A scoping review of adverse visual outcomes among preterm infants without, versus those with, retinopathy of prematurity.

  2025cites this paper
• The Burden of Retinopathy of Prematurity in Albania: A Nationwide Observational Study

  2025influential citation
• Evaluating the G-ROP criteria sensitivity for type 1 ROP in a North American cohort.

  2025cites this paper
• Conbercept versus laser for the treatment of infants with Zone II retinopathy of prematurity.

  2024cites this paper
• Artificial Intelligence Poised to Improve Retinopathy of Prematurity Screening.

  2024cites this paper
• Efficacy of an Indian Bevacizumab BIOSimilar (BEVATAS) for Type 1 and Aggressive Posterior Retinopathy of Prematurity (BIOS-ROP Study)

  2024cites this paper
• Implementation of optical coherence tomography in retinopathy of prematurity screening

  2024cites this paper
• Clinical Risk Factors for Retinopathy of Prematurity Reactivation after Intravitreal Anti-Vascular Endothelial Growth Factor Injection.

  2024cites this paper
• Refractive Outcomes after Treatment in Patients with Retinopathy of Prematurity at Around 1 Year of Age

  2024cites this paper
• Incidence and Risk Factors of Retinopathy of Prematurity in Southeastern Iran: A Retrospective Cohort Study

  2024cites this paper
• Platelet characteristics in extremely preterm infants after fatty acid supplementation: a randomized controlled trial

  2024cites this paper
• Efficacy and Safety of Prophylactic Agents in Prevention of Retinopathy of Prematurity: A Systematic Review and Meta-analysis of Randomised Controlled Trials

  2024cites this paper
• VGG-ST: A VGG-Swin Transformer-Based Model for ROP Disease Diagnosis

  2024cites this paper
• Comparing nSOFA, CRIB-II, and SNAPPE-II for predicting mortality and short-term morbidities in preterm infants ≤32 weeks gestation

  2024cites this paper
• Visual and refractive outcome after 12 years of treatment of type 1 prethreshold retinopathy of prematurity.

  2024influential citation
• Outcomes and Need for Additional Interventions Following Intravitreal Bevacizumab for Retinopathy of Prematurity.

  2024cites this paper
• A Moving Target: Studying the Effect of Continuous Transcutaneous CO2 Monitoring in ELBW Infants During an Equipoise Shift

  2024cites this paper